| Nereida Esparza, MD | |
|
3231 Euclid Ave, 5th Floor, Berwyn, IL 60402-3471 | |
| (708) 783-2000 | |
| (708) 783-3656 |
| Full Name | Nereida Esparza |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 3231 Euclid Ave, Berwyn, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013233006 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 125-058895 (Illinois) | Secondary |
| 207Q00000X | Family Medicine | 036131923 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Macneal Hospital | Berwyn, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loyola Medical Group Llc | 6305109547 | 91 |
News Archive
Brushing twice a day for at least two minutes is a basic hygiene rule. According to a new survey from the Australia's Oral Health Tracker, only half of the Australian adults brush twice a day regularly. Australia's Oral Health Tracker includes experts such as dental researchers, clinicians as well as policy and public health experts. This report comes on World Oral Health Day and is released by the ADA
Groundbreaking human clinical trial for type 1 diabetes to start this spring in Pittsburgh - Children's Hospital of Pittsburgh of UPMC researchers reverse juvenile diabetes in animal model; Phase 1 clinical trial approved by FDA.
"The best way to help the millions of hungry people in countries that receive food aid get rid of their corrupt and incompetent rulers - and to ensure that their children will never go hungry in future — is to starve them now. That will turn them into raging, unstoppable anti-government regime changers," writes Nation Media Group Executive Editor Charles Onyango-Obbo in an East African opinion piece.
Alba Therapeutics Corporation announced today the positive results of their Phase IIb trial evaluating its investigational product, larazotide acetate, a first-in-class tight junction regulator, intended for the treatment of patients with celiac disease (CeD).
Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway's activity also decreases inflammation.
› Verified 6 days ago
| Entity Name | Gottlieb Community Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013415603 PECOS PAC ID: 3375442999 Enrollment ID: O20180420000980 |
News Archive
Brushing twice a day for at least two minutes is a basic hygiene rule. According to a new survey from the Australia's Oral Health Tracker, only half of the Australian adults brush twice a day regularly. Australia's Oral Health Tracker includes experts such as dental researchers, clinicians as well as policy and public health experts. This report comes on World Oral Health Day and is released by the ADA
Groundbreaking human clinical trial for type 1 diabetes to start this spring in Pittsburgh - Children's Hospital of Pittsburgh of UPMC researchers reverse juvenile diabetes in animal model; Phase 1 clinical trial approved by FDA.
"The best way to help the millions of hungry people in countries that receive food aid get rid of their corrupt and incompetent rulers - and to ensure that their children will never go hungry in future — is to starve them now. That will turn them into raging, unstoppable anti-government regime changers," writes Nation Media Group Executive Editor Charles Onyango-Obbo in an East African opinion piece.
Alba Therapeutics Corporation announced today the positive results of their Phase IIb trial evaluating its investigational product, larazotide acetate, a first-in-class tight junction regulator, intended for the treatment of patients with celiac disease (CeD).
Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway's activity also decreases inflammation.
› Verified 6 days ago
| Entity Name | Loyola Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376041954 PECOS PAC ID: 6305109547 Enrollment ID: O20180420002063 |
News Archive
Brushing twice a day for at least two minutes is a basic hygiene rule. According to a new survey from the Australia's Oral Health Tracker, only half of the Australian adults brush twice a day regularly. Australia's Oral Health Tracker includes experts such as dental researchers, clinicians as well as policy and public health experts. This report comes on World Oral Health Day and is released by the ADA
Groundbreaking human clinical trial for type 1 diabetes to start this spring in Pittsburgh - Children's Hospital of Pittsburgh of UPMC researchers reverse juvenile diabetes in animal model; Phase 1 clinical trial approved by FDA.
"The best way to help the millions of hungry people in countries that receive food aid get rid of their corrupt and incompetent rulers - and to ensure that their children will never go hungry in future — is to starve them now. That will turn them into raging, unstoppable anti-government regime changers," writes Nation Media Group Executive Editor Charles Onyango-Obbo in an East African opinion piece.
Alba Therapeutics Corporation announced today the positive results of their Phase IIb trial evaluating its investigational product, larazotide acetate, a first-in-class tight junction regulator, intended for the treatment of patients with celiac disease (CeD).
Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway's activity also decreases inflammation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nereida Esparza, MD 3231 Euclid Ave, 5th Floor, Berwyn, IL 60402-3471 Ph: (708) 783-2000 | Nereida Esparza, MD 3231 Euclid Ave, 5th Floor, Berwyn, IL 60402-3471 Ph: (708) 783-2000 |
News Archive
Brushing twice a day for at least two minutes is a basic hygiene rule. According to a new survey from the Australia's Oral Health Tracker, only half of the Australian adults brush twice a day regularly. Australia's Oral Health Tracker includes experts such as dental researchers, clinicians as well as policy and public health experts. This report comes on World Oral Health Day and is released by the ADA
Groundbreaking human clinical trial for type 1 diabetes to start this spring in Pittsburgh - Children's Hospital of Pittsburgh of UPMC researchers reverse juvenile diabetes in animal model; Phase 1 clinical trial approved by FDA.
"The best way to help the millions of hungry people in countries that receive food aid get rid of their corrupt and incompetent rulers - and to ensure that their children will never go hungry in future — is to starve them now. That will turn them into raging, unstoppable anti-government regime changers," writes Nation Media Group Executive Editor Charles Onyango-Obbo in an East African opinion piece.
Alba Therapeutics Corporation announced today the positive results of their Phase IIb trial evaluating its investigational product, larazotide acetate, a first-in-class tight junction regulator, intended for the treatment of patients with celiac disease (CeD).
Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway's activity also decreases inflammation.
› Verified 6 days ago
Mr. Micah James Leestma, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3231 Euclid Ave, 5th Floor, Berwyn, IL 60402 Phone: 708-783-2000 Fax: 708-783-3656 | |
Maria Ramirez, Family Medicine Medicare: Medicare Enrolled Practice Location: 3249 Oak Park Ave, Berwyn, IL 60402 Phone: 708-783-9100 | |
Bradford S. Wainer, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6840 Windsor Ave, Berwyn, IL 60402 Phone: 708-484-0042 Fax: 708-749-5489 | |
Dr. Catherine Anichini, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6326 Cermak Rd, Berwyn, IL 60402 Phone: 708-303-9234 Fax: 305-698-6536 | |
Elsa Valero, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6425 Cermak Rd, Berwyn, IL 60402 Phone: 708-484-0044 | |
Dr. Ron Chacko, Family Medicine Medicare: Medicare Enrolled Practice Location: 7000 Cermak Rd, Berwyn, IL 60402 Phone: 708-484-8090 Fax: 708-445-4444 |